文献速递细菌感染、耐药与抗菌药物

破坏膜适应恢复抗生素对多重耐药肠球菌的体内疗效并增强人中性粒细胞杀菌

Disrupting Membrane Adaptation Restores In Vivo Efficacy of Antibiotics Against Multidrug-Resistant Enterococci and Potentiates Killing by Human Neutrophils.
PubMed 文献 · J Infect Dis · 2019-01-01

本研究利用秀丽隐杆线虫达托霉素治疗模型和鼠腹膜炎模型,发现破坏LiaR介导的细胞膜适应可恢复达托霉素对粪肠球菌和耐药屎肠球菌的体内活性,并增强人中性粒细胞对二者的清除能力。

要点

  • 破坏LiaR介导的膜适应可恢复达托霉素对耐药肠球菌的体内疗效。
  • 膜适应改变增强人中性粒细胞清除粪肠球菌和多重耐药屎肠球菌的能力。
  • 靶向膜适应反应是恢复抗生素活性、防耐药并增强先天免疫的概念验证策略。

核心结论

  • 靶向细胞膜适应反应可恢复抗生素体内活性、防止耐药并增强先天免疫系统杀灭感染细菌的能力。

研究设计与样本

  • 利用粪肠球菌实验室株建立新型秀丽隐杆线虫达托霉素治疗模型。
  • 利用达托霉素耐药屎肠球菌临床株建立鼠腹膜炎模型。
  • 评估人多形核中性粒细胞对粪肠球菌和多重耐药屎肠球菌的清除能力。

主要发现

  • 破坏LiaR介导的细胞膜适应可恢复达托霉素在秀丽隐杆线虫模型中的体内活性。
  • 在鼠腹膜炎模型中,LiaR效应同样见于达托霉素耐药屎肠球菌临床株。
  • 改变细胞膜反应可增强人中性粒细胞对粪肠球菌和多重耐药屎肠球菌的清除。

临床怎么用

  • 靶向LiaFSR/LiaR介导的膜适应反应可能作为恢复达托霉素对耐药肠球菌体内疗效的辅助策略。
  • 该策略可能同时增强中性粒细胞对耐药肠球菌的清除,但尚需临床验证。

局限性

  • 研究使用秀丽隐杆线虫模型和鼠腹膜炎模型,尚未在人体中验证。
  • 研究为概念验证,未报告临床结局或剂量方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Daptomycin resistance in enterococci is often mediated by the LiaFSR system, which orchestrates the cell membrane stress response. Activation of LiaFSR through the response regulator LiaR generates major changes in cell membrane function and architecture (membrane adaptive response), permitting the organism to survive the antibiotic attack. Here, using a laboratory strain of Enterococcus faecalis, we developed a novel Caenorhabditis elegans model of daptomycin therapy and showed that disrupting LiaR-mediated cell membrane adaptation restores the in vivo activity of daptomycin. The LiaR effect was also seen in a clinical strain of daptomycin-resistant Enterococcus faecium, using a murine model of peritonitis. Furthermore, alteration of the cell membrane response increased the ability of human polymorphonuclear neutrophils to readily clear both E. faecalis and multidrug-resistant E. faecium. Our results provide proof of concept that targeting the cell membrane adaptive response restores the in vivo activity of antibiotics, prevents resistance, and enhances the ability of the innate immune system to kill infecting bacteria.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Rincon S, Panesso D, Miller WR, et al. Disrupting Membrane Adaptation Restores In Vivo Efficacy of Antibiotics Against Multidrug-Resistant Enterococci and Potentiates Killing by Human Neutrophils. J Infect Dis. 2019. PMID: 30938438. doi:10.1093/infdis/jiz131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。